Debt crises between a country and an international lender as a two-period game

被引:0
|
作者
Hausken, Kjell [1 ]
Welburn, Jonathan W. [2 ]
机构
[1] Univ Stavanger, Fac Sci & Technol, N-4036 Stavanger, Norway
[2] RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA
关键词
Game theory; Country; Debt; Loan; Borrow; Default; Consumption; Economic risk; Greece; EU; ECB; IMF; Sensitivity analysis; GROWTH; MODEL;
D O I
10.1016/j.iref.2024.02.034
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
A two-period game between a country and an international lender is developed. In each period the country can repay debt, borrow from international credit markets, loan from an international lender, or default. The international lender can approve or deny the loan. The risk averse country maximizes a time-discounted utility incorporating its consumption. The international lender maximizes a time-discounted utility which values the country's consumption growth positively, and the debt-to-endowment ratio, the loan-to-endowment ratio, and the default penalty negatively. The subgame perfect equilibria are determined with backward induction. It is shown analytically that a country borrows less from international credit markets if it obtains a loan from an international lender and, intuitively, if its endowment increases. In contrast, the country borrows more if its future endowment (in period 2) can be expected to increase, or its initial borrowing is high. The model is simulated applying empirical data from the 2010 Greek crisis. The simulations illustrate how the country consumes in the two periods depending on whether the international lender approves or denies a loan. The impact is assessed of time discounting, risk aversion, default penalties, the country's endowment, interest rates, how the international lender values various characteristics of the country, and initial borrowing and consumption before the game starts.
引用
收藏
页码:704 / 723
页数:20
相关论文
共 50 条
  • [41] Between the West and Russia: Moldova's international brokers in a two-level game
    Morar, Stefan
    Dembinska, Magdalena
    EURASIAN GEOGRAPHY AND ECONOMICS, 2021, 62 (03) : 293 - 318
  • [42] Dose relationship between insulin detemir and NPH: A multi-centre, open, two-period trial in type 2 diabetic patients
    Schmitz, O
    Gray, R
    Kristensen, A
    Qwist, A
    Axelsen, M
    DIABETOLOGIA, 2001, 44 : A207 - A207
  • [43] Relative bioavailability of diazoxide, manufactured at two different international locations, in healthy participants under fasting conditions: an open-label, two-stage, adaptive, sequential two-period crossover study
    Martin Otto Behm
    Jialin Xu
    Deborah Panebianco
    Paul Fackler
    AAPS Open, 3 (1)
  • [44] 'In the interest of your bank and our country': Two encounters between China and the International Chamber of Commerce
    Lin, Yi-Tang
    David, Thomas
    Eichenberger, Pierre
    MODERN ASIAN STUDIES, 2023, 57 (04) : 1387 - 1414
  • [45] Pharmacokinetic Interaction Between Rosuvastatin and Telmisartan in Healthy Korean Male Volunteers: A Randomized, Open-label, Two-period, Crossover, Multiple-dose Study
    Son, Mijeong
    Kim, Yukyung
    Lee, Donghwan
    Roh, Hyerang
    Son, Hankil
    Guk, Jinju
    Jang, Seong Bok
    Nam, Su Youn
    Park, Kyungsoo
    CLINICAL THERAPEUTICS, 2014, 36 (08) : 1147 - 1158
  • [46] Strategic Investment in an International Infrastructure Capital: Nonlinear Equilibrium Paths in a Dynamic Game between Two Symmetric Countries
    Yanase, Akihiko
    Long, Ngo Van
    MATHEMATICS, 2021, 9 (01) : 1 - 24
  • [47] A Single-blind, Randomized, Single-dose, Two-sequence, Two-period, Crossover Study to Assess the Bioequivalence between Two Oral Tablet Formulations of Rivaroxaban 20 mg in Healthy Mexican Volunteers
    Genis-Najera, Luis
    Sanudo-Maury, Maria Elena
    Moquete, Trinifer
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (07): : 826 - 831
  • [48] NO PHARMACOKINETIC DRUG-DRUG INTERACTION BETWEEN TROPIFEXOR AND ATAZANAVIR: AN OPEN-LABEL, SINGLE-SEQUENCE, TWO-PERIOD CROSSOVER STUDY IN HEALTHY SUBJECTS.
    Chen, J.
    Gu, J.
    Choudhury, S.
    Hackling, M.
    Shah, B.
    Prince, W.
    Woessner, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S44 - S44
  • [49] A Two-Period Open-Label, Single-Dose Crossover Study in Healthy Volunteers to Evaluate the Drug–Drug Interaction Between Cimetidine and Inhaled Extrafine CHF 5993
    Fabrizia Mariotti
    Giorgia Ciurlia
    Luca Spaccapelo
    Annamaria Muraro
    Daniela Acerbi
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 269 - 279
  • [50] A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study)
    Staskin, David
    Herschorn, Sender
    Fialkov, Jonathan
    Tu, Le Mai
    Walsh, Terry
    Schermer, Carol R.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2018, 29 (02) : 273 - 283